EAP SPRING MEETING 2023 | PADOVA, ITALY

May 18, 2023 @ 6:00 pm – May 20, 2023 @ 8:00 pm UTC+1

This Event Passed

Registration is open to National Delegates of EAP, Young EAP members and official delegates from UEMS Subspecialty Societies or affiliated/related societies.

Register Now!

The EAP Spring Meeting will take place in Padova from 18-20 May 2023 (in-person only) alongside the the EAP Congress and MasterCourse in Padova, Italy.

 

 

Located in the heart of North East, an area of Italian industrial excellence, and a hotbed of innovative ideas and forward-looking entrepreneurial projects, Padova is confirmed as a city full of stimuli and surprises.

Since many delegates are supported by their national societies to attend the EAP Spring Meeting, it was decided that registration will take place separately from the EAP Congress and MasterCourse.

 

Social events overlap and the accommodation options will be similar for the Spring Meeting and MasterCourse.

Please see the details of the meeting below:

Registration for the Spring Meeting:

Register & book Accommodation.

Spring Meeting venue

Fiera di Padova, located in Via Niccolò Tommaseo
59, 35131
Padova Italy.

View Venue Website

Please download the agenda of the respective sessions below

Primary Care Council Agenda
Secondary-Tertiary Care Council Agenda
EBP Agenda
General Assembly Agenda

Programme

EAP Executive Committee Meeting (closed meeting)

yEAP Chair: Ivan Bambir  

Lunch and Networking (included in registration)

  Primary Care Council Chair: Zachi Grossman  

European Board of Paediatrics Chair: Liviana da Dalt    

 Lunch and Networking (included in registration)

 Secondary-Tertiary Care Council Chair: Ketil Stordal  

 EAP General Assembly Chair: Adamos Hadjipanayis  

 EAP Congress Networking Dinner (1 ticket included in registration, if you select the option)  

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more